Despite these limitations, we focused on VCP’s role in the HCC tumor microenvironment, exploring how it suppresses CD8+T cells function via downstream metabolites, particularly G3P, which links tumor metabolism with immune dysfunction. The gene discussed is VCP; the disease is hepatocellular carcinoma.